AbCellera Biologics Inc. v. Bruker Cellular Analysis, Inc.

Good Law
United States District Court, Northern District of CaliforniaApril 16, 20254:20-cv-08624California1,828 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 5 ABCELLERA BIOLOGICS INC, et al., Case No. 20-cv-08624-JST (VKD)

Plaintiffs,

ORDER RE APRIL 14, 2025

v. DISCOVERY DISPUTE RE KADIA

AND MUNCH DEPOSITIONS

BRUKER CELLULAR ANALYSIS, Re: Dkt. No. 334 Defendant.

11 AbCellera Biologics, Inc. (“AbCellera”) and The University of British Columbia (“UBC”) (collectively, “AbCellera”) and defendant Bruker Cellular Analysis, Inc. (“Bruker Cellular”) ask the Court to resolve their dispute regarding AbCellera’s requests for depositions of Siddhartha Kadia and Mark Munch. Dkt. No. 334. The Court finds this dispute suitable for resolution without oral argument. Civil L.R. 7-1(b). For the reasons explained below, the Court denies AbCellera’s requests for relief. I. BACKGROUND As explained by the parties, Siddartha Kadia is the former CEO of PhenomeX. Dkt. No. 334 at 1. According to Bruker Cellular, PhenomeX was the successor to the original defendant in this action, Berkeley Lights. Id. at 4. Bruker…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.